نتایج جستجو برای: nccn guidelines

تعداد نتایج: 143623  

Journal: :Journal of the National Comprehensive Cancer Network 2017

Journal: :Investigacion y educacion en enfermeria 2014
Cristiane Decat Bergerot Tereza Cristina Cavalcanti Ferreira de Araujo

OBJECTIVE Assess the prevalence of distress and quality of life of cancer patients over the course of chemotherapy. METHODOLOGY Longitudinal prospective study addressing 200 patients. The Distress Thermometer (DT) and Functional Assessment of Chronic Illness Therapy-General (FACT-G), as indicators of distress and quality of life, were applied at three points in time during chemotherapy: the f...

Journal: :Journal of the National Comprehensive Cancer Network 2015

Journal: :Journal of the National Comprehensive Cancer Network 2017

Journal: :Journal of the National Comprehensive Cancer Network 2016

Journal: :Cancer control : journal of the Moffitt Cancer Center 2006
Alan F List

Lenalidomide has emerged as an effective therapeutic alternative for the management of anemia in lower-risk myelodysplastic syndromes (MDS). Compelling results from phase I and phase II clinical studies prompted the US Food and Drug Administration to approve lenalidomide for the treatment of transfusion-dependent MDS patients with interstitial deletion of chromosome 5q [del(5q)]. Subsequently, ...

2016
Thomas M. Polasek Karen Ambler Hamish S. Scott Michael J. Sorich Peter A. Kaub Andrew Rowland Michael D. Wiese Ganessan Kichenadasse Nimit Singhal Andrew A. Somogyi Thomas Polasek

Many patients with solid tumours are treated with targeted pharmacotherapy based on the results of genetic testing ('precision medicine'). This study investigated the use of targeted drugs after OncoFOCUS™+ KIT screening in patients with malignant melanoma, non-small cell lung cancer and metastatic colorectal cancer, and then audited the results against the National Comprehensive Cancer Network...

Journal: :Ugeskrift for laeger 1964
M SAKURAI S NOSAKA

Overview In 2010, approximately 12,330 people were diagnosed with and 8950 died of acute myeloid leukemia (AML).1 As the population ages, the incidence of AML, along with myelodysplasia, seems to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of childhood tumors and young adulthood, such as Hodgkin disease, sarcomas, breas...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2006
Therese B Bevers Benjamin O Anderson Ermelinda Bonaccio Patrick I Borgen Saundra Buys Mary B Daly Peter J Dempsey William B Farrar Irving Fleming Judy E Garber Randall E Harris Mark Helvie Susan Hoover Helen Krontiras Sara Shaw Eva Singletary Celette Sugg Skinner Mary Lou Smith Theodore N Tsangaris Elizabeth L Wiley Cheryl Williams

Overview Women in the United States have a 12.3% estimated lifetime risk for developing breast cancer (i.e., 1 in 8 women).1 In 2009, an estimated 194,290 cases of invasive breast cancer (192,370 women and 1919 men) and 62,280 cases of female carcinoma in situ of the breast will be diagnosed in the United States, with 40,610 deaths from invasive breast cancer predicted.2 However, mortality from...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید